<DOC>
	<DOCNO>NCT00746616</DOCNO>
	<brief_summary>The purpose study gather clinical information safety efficacy resurface device young , active patient advance hip disease . Study enrollment temporarily suspend due change surgical technique .</brief_summary>
	<brief_title>Durom ( R ) Hip Resurfacing System Multicenter Trial</brief_title>
	<detailed_description>Safety evaluate base frequency incidence device related adverse event unanticipated adverse device event . The efficacy measure compare overall functional performance base Harris Hip Score , implant survivorship , radiographic parameter , include radiolucencies , osteolysis , stem subsidence , cup migration , change cup angle change femoral shaft angle .</detailed_description>
	<criteria>Patient selection without bias race gender Patient great equal 18 less equal 65 year age . Female patient : actively practice contraceptive method , surgically sterilize , postmenopausal Preoperative Harris Hip Score less equal 70 . Primary surgical hip candidate , suffer hip pain and/or disability due degenerative joint disease ( inflammatory noninflammatory ) , base physical examination history , include follow diagnosis : noninflammatory degenerative joint disease ( NIDJD ) , e.g . avascular necrosis osteoarthritis inflammatory joint disease ( IJD ) , e.g . rheumatoid arthritis Patient willing able cooperate prescribe postoperative therapy . Patient willing able complete schedule followup evaluation describe Informed Consent . Patient participate Informed Consent process sign IRB approve Informed Consent . Patient acute , chronic , local systemic infection . Patient skeletally immature . Patient severe muscular , neural vascular disease endangers involve extremity . Patient insufficient acetabular femoral bone stock good anchorage implant unlikely impossible , include limited : patient severe osteopenia patient family history severe osteoporosis osteopenia patient osteonecrosis avascular necrosis ( AVN ) &gt; 50 % involvement femoral head ( regardless FICAT grade ) patient multiple cyst femoral head &gt; 1cm Patient total partial absence muscular ligamentous apparatus . Patient known moderate severe renal insufficiency . Patient known clinical condition may interfere patient outcome , include limited : immunocompromised condition ( AIDS ) , organ transplant recipient , high dos corticosteroid etc Patient severely overweight ( BMI &gt; 40 ) Operative ( ipsilateral ) Hip : Patient total prosthetic hip replacement device , surface arthroplasty endoprosthesis . Contralateral Hip : Patient hip replacement , surface arthroplasty endoprosthesis , within past 12 month , unless already enrol investigational study . Patient : prisoner mentally incompetent know alcohol drug abuser anticipate noncompliant Patient participate study investigational device ( drug , device biologic ) within past 12 month . Exception : previous enrollment Durom Hip Resurfacing System clinical study . Patient know allergy one constituent implant , e.g . cobalt , chromium , nickel , etc .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Total Hip Arthroplasty ,</keyword>
	<keyword>Acetabular Cup ,</keyword>
	<keyword>Hip Resurfacing</keyword>
	<keyword>Young ,</keyword>
	<keyword>active</keyword>
	<keyword>patient</keyword>
</DOC>